Prevention and treatment of experimental glomerulonephritis in mice by urokinase.
D000208:Acute Disease; D000818:Animals; D001557:Benzenesulfonates; D001798:Blood Proteins; D001728:Dicumarol / Q000627:therapeutic use; D010450:Endopeptidases / Q000627:therapeutic use*; D005337:Fibrin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D006651:Histocytochemistry; D051379:Mice; D011108:Polymers; D012995:Solubility; D013291:Streptococcus / Q000276:immunology; D013997:Time Factors
D001557:Benzenesulfonates; D001798:Blood Proteins; D005343:Fibrinolytic Agents; D011108:Polymers; D001728:Dicumarol; D005337:Fibrin; D006493:Heparin; D010450:Endopeptidases